Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-06-07
1997-12-30
Wolski, Susan
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
4351722, 435 7021, 43524027, 435975, 436518, 436548, 436808, 436811, 5303871, 5303879, 5303881, 5303889, 5303891, 5303898, 5303911, 5303913, G01N 3353
Patent
active
057029091
ABSTRACT:
In a method of analyzing a body fluid sample for the presence of an analyte indicative of a physiological condition, comprising the steps of contacting the body fluid sample with an immunological binding partner which binds to the analyte, detecting binding of the immunological binding partner to the analyte, and correlating any detected binding to the physiological condition, the improvement comprising contacting the body fluid sample with an immunological binding partner which binds to ##STR1## wherein ##STR2## is hydroxylysyl pyridinoline or lysyl pyridinoline, and correlating any detected binding to degradation of type II collagen in vivo.
REFERENCES:
patent: 3600132 (1971-08-01), Goverde
patent: 4094646 (1978-06-01), Stern et al.
patent: 4312853 (1982-01-01), Timpl
patent: 4371374 (1983-02-01), Cerami et al.
patent: 4504587 (1985-03-01), Timpl et al.
patent: 5140103 (1992-08-01), Eyre
patent: 5532169 (1996-07-01), Eyre
Hanson, et al., "A Specific Immunoassay for Monitoring Human Bone Resorption: Quantitation of Type I Collagen Cross-linked N-Telopeptides in Urine," Journal of Bone and Mineral Research, 7:11; 1251-1258 (1992).
Lane, et al., "Immunofluorescent Localization of Structural Collagen Types in Endochondral Fracture Healing," Orthopaedic Transactions, VI(2):236 (1982).
Rennard, et al., "Enzyme-inked Immunoassay (ELISA) for Connective Tissue Components," Analytical Biochemistry, 104:205-214 (1980).
Foidart, et al., "Antibodies to Type II Collagen in Relapsing Polychondritis," The New England Journal of Medicine, 299:22; 1203-1207 (1978).
Linsenmayer, et al., "Monoclonal Antibodies to Connective Tissue Macromolecules: Type II Collagen," Biochemical and Biophysical Research Communications, 92:2; 440-446 (1980).
Posner, et al, "The Generation of Hybridomas Secreting Human Monoclonal Antibodies Reactive with Type II Collagen," Hybridoma, 8:2; 187-197 (1989).
Dusemund and Barrach, "Double-Antibody Enzyme-Linked Immunosorbent Microassay for Quantification of Collagen Types I and II," Journal of Immunological Methods, 50:255-268 (1982).
Srinivas, et al., "Quantitative immunoassays for type II collagen and its cyanogen bromide peptides," Journal of Immunological Methods, 159:53-62 (1993).
Gosslau and Barrach, "Enzyme-Linked Immunosorbent Microassay for Quantification of Specific Antibodies to Collagen Type I, II, III," Journal of Immunological Methods, 29:71-77 (1979).
Kittelberger-Ewert et al., Immunological Investigations, Production and specificity of antibodies against the central region of type II collagen, 17(1):49-61 (1988).
Chichester et al., Journal of Immunological Methods, Evidence for polyreactivity seen with monoclonal antibodies produced against type II collagen, 140:259-267 (1991).
Srinivas et al., Immunological Investigations, Production of type II collagen specific monoclonal antibodies, 23(2):85-98 (1994).
Black, et al., "Urinary excretion of the hydroxypyridinium cross links of collagen in patients with rheumatoid arthritis," Annals of the Rheumatic Diseases, 48:641-644 (1989).
Seibel, et al., "Urinary Hydroxy-pyridinium Crosslinks Provide Indices of Cartilage and Bone Involvement in Arthritic Diseases," the Journal of Rheumatology, 16:964-970 (1989).
Baldwin, et al., "Structure of cDNA clones coding for human type II procollagen: the a1(II) chain is more similar to the a1(I) chain than two other a chains of fibrillar collagens," Biochemistry Journal, 262:521-528 (1989).
Ala-Kokko, et al., "Structure of cDNA clones coding for the entire preproa1(III) chain of human type III procollagen: Differences in protein structure from type I procollagen and conservation of codon preferences," Biochemistry Journal, 260:509-516 (1989).
Seibel, "Komponenten der extrazllularen Gewebematrix als potentielle `Marker` des Bindegewebs-, Knorpel- und Knochenmetabolismus bei Erkrankungen des Bewegungsapparates," Zeitschrift fur Rheumatologie, 48:6-18 (1989).
Dodge and Poole, "Immunohistochemical Detection and Immunochemical Analysis of Type II Collagen Degradation in Human Normal, Rheumatoid, and Osteoarthritic Articular Cartilages and in Explants of Bovine Articular Cartilage Cultured with Interleukin 1," Journal of Clinical Investigation, 83:647-661 (1989).
Niemela, "Radioimmunoassays for Type III Procollagen Amino-Terminal Peptides In Humans," Clinical Chemistry, 31:1301-1304 (1985).
Sangiorgi, et al., "Isolation and partial characterization of the entire human proa1(II) collagen gene," Nucleic Acids Research, 13:2207-2225 (1985).
Loidl, et al., "Molecular cloning and carboxyl-propeptide analysis of human type III procollagen," Nucleic Acids Research, 12:9383-9394 (1984).
Wu and Eyre, "Identification of Hydroxypyridinium Cross-Linking Sites in Type II Collagen of Bovine Articular Cartilage," Biochemistry, 23:1805-1857 (1984).
Pierard, et al., "Radioimmunoassay for the Amino-Terminal Sequences of Type III Procollagen in Human Body Fluids Measuring Fragmented Precursor Sequences," Analytical Biochemistry, 141:127-136 (1984).
Rohde, et al., "Radioimmunoassay for type III procollagen peptide and its application to human liver disease," European Journal of Clinical Investigation, 9:451-459 (1979).
Russell, R.G.G., et al., "Biochemical Markers of Bone Turnover in Paget's Disease," Metab. Bone Dis. & Rel. Res., 4 & 5:255-262 (1981).
Drinkwater, B.L., et al., "Bone Mineral Density After Resumption of Menses in Amenorrheic Athletes," JAMA, 256:380-382 (1986).
Drinkwater, B.L., et al., "Bone Mineral Content of Amenorrheic and Eumenorrheic Athletes,"0 the New England Journal of Medicine, 311:5; 277-281 (1984).
Fujimoto, D., "Evidence for Natural Existence of Pyridinoline Crosslink in Collagen," Biochemical and Biophysical Research Communications, 93:948-953 (1980).
Yamauchi, M. et al., "A Comparative Study of the Distribution of the Stable Crosslink, Pyridinoline, in Bone Collagens from Normal, Osteoblastoma, and Vitamin D-Deficient Chicks," Biochemical and Biophysical Research Communications, 102:59-65 (1981).
Kuboki, Y., et al., "Location of the Intermolecular Crosslinks in Bovine Dentin Collagen, Solubilization with Trypsin and Isolation of Cross-Link Peptides Containing Dihydroxylysinonorleucine and Pyridinoline," Biochemical and Biophysical Research Communications, 102:119-126 (1981).
Gunja-Smith, Z. and Boucek, R.J., "Collagen cross-linking compounds in human urine," Biochemical Journal, 197:759-762 (1981).
Tsuchikura, O., et al., "Pyridinoline Fluorescence in Cyanogen Bromide Peptides of Collagen," Biochemical and Biophysical Research Communications, 102:1203-1208 (1981).
Tsuda, M., et al., "Pyridinoline is a Real Moiety of Collagen," Biochemical and Biophysical Research Communications, 104:1407-1412 (1982).
Robins, S.P., "An enzyme-linked immunoassay for the collagen cross-link pyridinoline," Biochemical Journal, 207:617-620 (1982).
Banes, A.J., et al., "Nonmineralized and Mineralized Compartments of Bone: the Role of Pyridinoline in Nonmineralized Collagen," Biochemical and Biophysical Research Communications, 113:975-981 (1983).
Fujimoto, D., et al., "Analysis of Pyridinoline, a Cross-Linking Compound of Collagen Fibers, in Human Urine," J. Biochem., 94:1133-1136 (1983).
Eyre, D.R., et al., "Cross-Linking in Collagen and Elastin," Ann. Rev. Biochem., 53:717-748 (1984).
Light, N. and Bailey, A.J., "Collagen crosslinks: Location of pyridinoline in type I collagen," FEBS 2409, 182:503-508 (1985).
Wu, J-J. and Eyre, D.R., "Fine Powdering Exposes the Mineral-Protected Collagen of Bone to Protease Digestion," Calcif. Tissue Int., 42:243-247 (1988).
Fujimoto, D., et al., "Pyridinoline, A Non-Reducible Crosslink of Collagen. Quantitative Determination, Distribution, and Isolation of a Crosslinked Peptide," Chemical Abstracts 89(11):148, (Sep. 11, 1978).
Black, D., et al., "Quantitative Analysis of the Pyridinium Crosslinks of Collagen in Urine using Ion-Paired Reversed-Phase High-Performance Liquid Chromatography," Chemical Abstracts 108(21):354, (May 23, 1988).
Fujimoto, D., et al., "Analysis of Pyridinoline, A Cross-Linking Compound of Collagen Fibers, in Human Urine," Chemical
Washington Research Foundation
Wolski Susan
LandOfFree
Methods of detecting collagen type II degradation in vivo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of detecting collagen type II degradation in vivo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of detecting collagen type II degradation in vivo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-201370